AbbVie (ABBV)

EBITDA Growth

49.58%

TTM · Period ending:

ABBV logo

ABBV EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported49.58%
ABBV TTM EBITDA YoY % (21.19% → 49.58%)
High-resolution chart · PNG

ABBV ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AbbVie EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
49.5763%
14.1691%
18.2361%
-29.8019%
-21.7007%
-19.9125%
-13.1726%
-4.1088%
-15.5996%
-6.5306%
-28.965%
-24.917%
-12.7514%
-20.0008%
1.007%
38.4144%
41.9687%
67.0311%
94.2141%
19.7146%
34.743%
13.8631%
0.7851%
133.8231%
81.2279%
58.8307%
47.136%
-44.2587%
-35.3204%
-26.8155%
-19.9191%
5.0547%
-0.2368%
5.673%
2.5395%
13.0382%
17.2701%
20.7569%
23.4146%
93.4731%
131.2994%
136.0872%
128.7308%
-15.0092%
-38.396%
-43.2325%
-45.0911%
-10.3729%
-5.3681%
-5.9179%
-3.1988%
-3.8607%
26.375%
23.113%
21.1902%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.